Table 7.
The COX risk model analysis of overall survival (OS) and disease-free survival (DFS) of miR-141-3p
| Variables | Overall survival (OS) | Disease free survival (DFS) | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
| value | HR | 95%CI | value | value | HR | 95%CI | value | |
| Age | 0.288 | 0.689 | ||||||
| Gender | 0.106 | 0.108 | ||||||
| Tumor site | 0.858 | 0.768 | ||||||
| Tumor subtype | 0.063 | 0.057 | ||||||
| Pathological classifications | 0.054 | 0.106 | ||||||
| Tumor size | 0.002 | 1.421 | 0.665–3.036 | 0.364 | 0.002 | 1.589 | 0.770–3.276 | 0.21 |
| Histopathology classification | 0.0503 | 0.062 | ||||||
| Tumor infiltrating depth | 0.001 | 1.95 | 0.709–5.364 | 0.196 | 0.001 | 1.974 | 0.770–5.061 | 0.157 |
| Number of metastatic lymph nodes | 0.001 | 1.488 | 0.867–2.555 | 0.149 | 0.001 | 1.508 | 0.877–2.592 | 0.138 |
| Metastatic lymph nodes ration | 0.001 | 0.217 | 0.065–0.729 | 0.013 | 0.001 | 0.244 | 0.084–0.705 | 0.009 |
| AJCC 8th TNM stage | 0.001 | 0.757 | 0.131–4.384 | 0.756 | 0.001 | 0.941 | 0.194–4.571 | 0.94 |
| Vascular nerve infiltrating | 0.007 | 0.971 | 0.448–2.106 | 0.942 | 0.009 | 0.899 | 0.430–1.878 | 0.776 |
| adjuvant chemotherapy | 0.346 | 0.196 | ||||||
| Lauren classification | 0.012 | 0.562 | 0.347–0.911 | 0.019 | 0.004 | 0.502 | 0.314–0.804 | 0.004 |
| miR-141-3p | 0.007 | 0.408 | 0.169–0.988 | 0.047 | 0.036 | 0.563 | 0.258–1.228 | 0.149 |
0.05, statistical significance.